Merck & Co.'s latest marketcap:
As of 06/13/2026, Merck & Co.'s market capitalization has reached $294.03 B. According to our data, Merck & Co. is the 53th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 294.03 B |
| Revenue (ttm) | 65.77 B |
| Net Income (ttm) | 8.94 B |
| Shares Out | 2.47 B |
| EPS (ttm) | 3.58 |
| Forward PE | 19.27 |
| Ex-Dividend Date | 06/15/2026 |
| Earnings Date | 07/28/2026 |
Merck & Co.'s yearly market capitalization.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 06/13/2026 | $294.03 B | 13.06% | 53 |
| 12/31/2025 | $261.26 B | 3.82% | 69 |
| 12/31/2024 | $251.65 B | -8.91% | 40 |
| 12/29/2023 | $276.26 B | -1.79% | 32 |
| 12/30/2022 | $281.3 B | 45.31% | 30 |
| 12/31/2021 | $193.59 B | -6.46% | 62 |
| 12/31/2020 | $206.96 B | -10.62% | 42 |
| 12/31/2019 | $231.56 B | 16.54% | 30 |
| 12/31/2018 | $198.69 B | 29.61% | 31 |
| 12/29/2017 | $153.3 B | -5.55% | 50 |
Company Profile
About Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare company operating in two primary segments:
- Pharmaceutical
- Animal Health
Pharmaceutical Segment
The company provides human health pharmaceuticals across multiple therapeutic areas, including:
- Oncology
- Vaccines
- Hospital acute care
- Cardiovascular
- Virology
- Neuroscience
- Diabetes
Key brands include Keytruda, Gardasil, Januvia, Janumet, Lagevrio, and Belsomra.
Animal Health Segment
Merck offers comprehensive veterinary solutions through:
- Livestock Products: Nuflor, Bovilis, Banamine, Safe-Guard
- Companion Animal Products: Bravecto, Sentinel, Caninsulin/Vetsulin
- Animal Intelligence Solutions: Allflex identification and monitoring systems
Strategic Collaborations
The company maintains partnerships with leading organizations including:
- Daiichi Sankyo
- AstraZeneca PLC
- Eisai Co., Ltd.
- Bayer AG
- Moderna, Inc.
Founded: 1891
Headquarters: Rahway, New Jersey
Frequently Asked Questions
-
What is Merck & Co.'s (MRK) current market cap?As of 06/13/2026, Merck & Co. (including the parent company, if applicable) has an estimated market capitalization of $294.03 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Merck & Co. (MRK) rank globally by market cap?Merck & Co. global market capitalization ranking is approximately 53 as of 06/13/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.